eyestock

Sector: Healthсare

FY

Formycon AGXETRA Formycon Stock Report

Last reporting period 30 Jun, 2024

Updated 18 Sep, 2024

Last price

—

Market cap $B

0.971

Micro

Exchange

XETR - Xetra

View Section: Valuation

Formycon AG Financials

FY

Income Statement

Revenue

-N/A

‌

Growth Rates:

1 yearN/A

3 yearsN/A

5 yearsN/A

Operating income

-N/A

‌

Growth Rates:

1 yearN/A

3 yearsN/A

5 yearsN/A

Net income

-N/A

‌

Growth Rates:

1 yearN/A

3 yearsN/A

5 yearsN/A

Revenue analysis

‌

100%

Operating income

Balance Sheet

Assets

-

Equity

-

‌

Cash and equivalents

-

Debt

-

‌

Financial Position Analysis

‌

Cash Flow Statement

Free Cash Flow To Equity

-N/A

‌

Growth Rates:

1 yearN/A

3 yearsN/A

5 yearsN/A

Cash Flow From Operating Activities

-N/A

‌

Growth Rates:

1 yearN/A

3 yearsN/A

5 yearsN/A

Formycon AG fundamental analysis for trailing twelve months (TTM)

Gross Margin

-

‌

Average:

1 year0%

3 years0%

5 years0%

Operating margin

-

‌

Average:

1 year0%

3 years0%

5 years0%

Net Profit Margin

-

‌

Average:

1 year0%

3 years0%

5 years0%

Earnings quality

-

‌

Average:

1 year0%

3 years0%

5 years0%

Solvency Indicators

CFO / Debt ratio

-

‌

Average:

1 year0

3 years0

5 years0

Current ratio

-

‌

Average:

1 year0

3 years0

5 years0

Debt / Equity ratio

-

‌

Average:

1 year0

3 years0

5 years0

Efficiency Indicators

ROE

-

‌

Average:

1 year0%

3 years0%

5 years0%

ROIC

-

‌

Average:

1 year0%

3 years0%

5 years0%

ROA

-

‌

Average:

1 year0%

3 years0%

5 years0%

Financial Leverage

-

‌

Average:

1 year0

3 years0

5 years0

Dupont Analysis

Net Profit Margin

x

Asset turnover

0.067

x

Financial Leverage

Stability Indicators

Net income growth rate

-

‌

Average growth rate (2y)

-

Growth rate volatility (2y)

-

‌

Average growth rate (5y)

-

Growth rate volatility (5y)

-

‌

View Section: Income Statement

Discover

Stock Analysis Screener Portfolio